Iovance Biotherapeutics, Inc.
EXPANSION OF TILS UTILIZING AKT PATHWAYS INHIBITORS

Last updated:

Abstract:

In some embodiments, methods of expanding tumor infiltrating lymphocytes using AKT pathway inhibitors and methods of using the expanded tumor infiltrating lymphocytes in the treatment of human diseases, including cancers, are disclosed.

Status:
Application
Type:

Utility

Filling date:

4 Nov 2019

Issue date:

3 Feb 2022